Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma

被引:73
作者
Fujisawa, Yasuhiro [1 ,2 ,3 ]
Yoshikawa, Shusuke [1 ,4 ]
Minagawa, Akane [1 ,5 ]
Takenouchi, Tatsuya [1 ,6 ]
Yokota, Kenji [1 ,7 ]
Uchi, Hiroshi [1 ,8 ]
Noma, Naoki [1 ,9 ]
Nakamura, Yasuhiro [1 ,10 ]
Asai, Jun [1 ,11 ]
Kato, Jiinji [1 ,12 ]
Fujiwara, Susumu [1 ,13 ]
Fukushima, Satoshi [1 ,14 ]
Uehara, Jiro [1 ,15 ]
Hoashi, Toshihiko [1 ,16 ]
Kaji, Tatsuya [1 ,17 ]
Fujimura, Taku [1 ,18 ]
Namikawa, Kenjiro [1 ,19 ]
Yoshioka, Manabu [1 ,20 ]
Murao, Naoki [1 ,21 ]
Ogata, Dai [1 ,22 ]
Matsuyama, Kanako [1 ,23 ]
Hatta, Naohito [1 ,24 ]
Shibayama, Yoshitsugu [1 ,25 ]
Fujiyama, Toshiharu [1 ,26 ]
Ishikawa, Masashi [1 ,27 ]
Yamada, Daisuke [1 ,28 ]
Kishi, Akiko [1 ,29 ]
Nakamura, Yoshiyuki [3 ]
Shimiauchi, Takatoshi [2 ,26 ]
Fujii, Kazuyasu [2 ,30 ]
Fujimoto, Manabu [3 ]
Ihn, Hironobu [2 ,14 ]
Katoh, Norito [2 ,11 ]
机构
[1] Japanese Melanoma Study Grp, Tsukuba, Ibaraki, Japan
[2] Japanese Skin Canc Soc, Prognosis & Stat Invest Comm, Kumamoto, Japan
[3] Univ Tsukuba, Dept Dermatol, Tsukuba, Ibaraki, Japan
[4] Shizuoka Canc Ctr, Dept Dermatol, Shizuoka, Japan
[5] Shinshu Univ, Dept Dermatol, Sch Med, Matsumoto, Nagano, Japan
[6] Niigata Canc Ctr, Dept Dermatol, Niigata, Japan
[7] Nagoya Univ, Dept Dermatol, Nagoya, Aichi, Japan
[8] Univ Kyushu, Dept Dermatol, Fukuoka, Fukuoka, Japan
[9] Osaka City Univ, Dept Dermatol, Osaka, Japan
[10] Saitama Med Univ, Dept Dermatol, Int Med Ctr, Hidaka, Japan
[11] Kyoto Prefectural Univ Med, Dept Dermatol, Kyoto, Japan
[12] Sapporo Med Univ, Dept Dermatol, Sapporo, Hokkaido, Japan
[13] Kobe Univ, Dept Dermatol, Kobe, Hyogo, Japan
[14] Kumamoto Univ, Dept Dermatol & Plast Surg, Kumamoto, Japan
[15] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan
[16] Nippon Med Sch, Dept Dermatol, Bunkyo Ku, Tokyo, Japan
[17] Okayama Univ, Dept Dermatol, Grad Sch Med, Okayama, Japan
[18] Tohoku Univ, Dept Dermatol, Grad Sch Med, Sendai, Miyagi, Japan
[19] Natl Canc Ctr, Dept Dermatol Oncol, Tokyo, Japan
[20] Univ Occupat & Environm Hlth, Dept Dermatol, Kitakyushu, Fukuoka, Japan
[21] Univ Hokkaido, Dept Plast Surg, Sapporo, Hokkaido, Japan
[22] Saitama Med Univ, Dept Dermatol, Hidaka, Japan
[23] Univ Gifu, Dept Dermatol, Gifu, Japan
[24] Toyama Prefectural Cent Hosp, Dept Dermatol, Toyama, Japan
[25] Fukuoka Univ, Dept Dermatol, Fukuoka, Fukuoka, Japan
[26] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka, Japan
[27] Saitama Prefectural Canc Ctr, Dept Dermatol, Saitama, Japan
[28] Univ Tokyo, Dept Dermatol, Tokyo, Japan
[29] Toranomon Gen Hosp, Dept Dermatol, Minato Ku, Tokyo, Japan
[30] Kagoshima Univ, Dept Dermatol, Kagoshima, Japan
来源
CANCER MEDICINE | 2019年 / 8卷 / 05期
关键词
acral; Asian; Epidemiology; Japanese; Melanoma; mucosal; ACRAL LENTIGINOUS MELANOMA; MALIGNANT-MELANOMA; METASTATIC MELANOMA; CUTANEOUS MELANOMA; MUTATIONAL BURDEN; IPILIMUMAB; NIVOLUMAB; ANTI-PD-1; CANCER; PROGNOSIS;
D O I
10.1002/cam4.2110
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The incidence of melanoma among those of an Asian ethnicity is lower than in Caucasians; few large-scale Asian studies that include follow-up data have been reported. Objectives To investigate the clinical characteristics of Japanese patients with melanoma and to evaluate the prognostic factors. Methods Detailed patient information was collected from the database of Japanese Melanoma Study Group of the Japanese Skin Cancer Society. The American Joint Committee on Cancer seventh Edition system was used for TNM classification. The Kaplan-Meier method and Cox proportional hazards model were used to estimate the impact of clinical and histological parameters on disease-specific survival in patients with invasive melanoma. Results In total, 4594 patients were included in this analysis. The most common clinical type was acral lentiginous melanoma (40.4%) followed by superficial spreading melanoma (20.5%), nodular melanoma (10.0%), mucosal melanoma (9.5%), and lentigo maligna melanoma (8.1%). The 5-year disease-specific survival for each stage was as follows: IA = 98.0%, IB = 93.9%, IIA = 94.8%, IIB = 82.4%, IIC = 71.8%, IIIA = 75.0%, IIIB = 61.3%, IIIC = 41.7%, and IV = 17.7%. Although multivariate analysis showed that clinical classifications were not associated with survival across all stages, acral type was an independent poor prognostic factor in stage IIIA. Conclusions Our study revealed the characteristics of melanoma in the Japanese population. The 5-year disease-specific survival of each stage showed a similar trend to that of Caucasians. While clinical classification was not associated with survival in any stages, acral type was associated with poor survival in stage IIIA. Our result might indicate the aggressiveness of acral type in certain populations.
引用
收藏
页码:2146 / 2156
页数:11
相关论文
共 32 条
  • [1] Final Version of 2009 AJCC Melanoma Staging and Classification
    Balch, Charles M.
    Gershenwald, Jeffrey E.
    Soong, Seng-jaw
    Thompson, John F.
    Atkins, Michael B.
    Byrd, David R.
    Buzaid, Antonio C.
    Cochran, Alistair J.
    Coit, Daniel G.
    Ding, Shouluan
    Eggermont, Alexander M.
    Flaherty, Keith T.
    Gimotty, Phyllis A.
    Kirkwood, John M.
    McMasters, Kelly M.
    Mihm, Martin C., Jr.
    Morton, Donald L.
    Ross, Merrick I.
    Sober, Arthur J.
    Sondak, Vernon K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) : 6199 - 6206
  • [2] Mucosal melanomas: A review
    Batsakis, JG
    Suarez, P
    [J]. ADVANCES IN ANATOMIC PATHOLOGY, 2000, 7 (03) : 167 - 180
  • [3] BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site
    Bauer, Juergen
    Buettner, Petra
    Murali, Rajmohan
    Okamoto, Ichiro
    Kolaitis, Nicholas A.
    Landi, Maria T.
    Scolyer, Richard A.
    Bastian, Boris C.
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2011, 24 (02) : 345 - 351
  • [4] Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy
    Bowyer, S.
    Prithviraj, P.
    Lorigan, P.
    Larkin, J.
    McArthur, G.
    Atkinson, V.
    Millward, M.
    Khou, M.
    Diem, S.
    Ramanujam, S.
    Kong, B.
    Liniker, E.
    Guminski, A.
    Parente, P.
    Andrews, M. C.
    Parakh, S.
    Cebon, J.
    Long, G. V.
    Carlino, M. S.
    Klein, O.
    [J]. BRITISH JOURNAL OF CANCER, 2016, 114 (10) : 1084 - 1089
  • [5] Treatment outcome of PD-1 immune checkpoint inhibitor in Asian metastatic melanoma patients: correlative analysis with PD-L1 immunohistochemistry
    Cho, Jinhyun
    Ahn, Soomin
    Yoo, Kwai Han
    Kim, Jung Han
    Choi, Sang-Hee
    Jang, Kee-Taek
    Lee, Jeeyun
    [J]. INVESTIGATIONAL NEW DRUGS, 2016, 34 (06) : 677 - 684
  • [6] Distinct sets of genetic alterations in melanoma
    Curtin, JA
    Fridlyand, J
    Kageshita, T
    Patel, HN
    Busam, KJ
    Kutzner, H
    Cho, KH
    Aiba, S
    Bröcker, EB
    LeBoit, PE
    Pinkel, D
    Bastian, BC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) : 2135 - 2147
  • [7] OPINION Explanations for worsening cancer survival
    de Vries, Esther
    Karim-Kos, Henrike E.
    Janssen-Heijnen, Maryska L. G.
    Soerjomataram, Isabelle
    Kiemeney, Lambertus A.
    Coebergh, Jan Willem W.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (01) : 60 - 63
  • [8] Survival of acral lentiginous melanoma in the National Cancer Institute of Colombia
    Duarte, C. A.
    Florez, J. P.
    Lopez, H. G.
    Meneses, M. X.
    de Vries, E.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (03) : 438 - 442
  • [9] Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients
    Fujisawa, Yasuhiro
    Yoshino, Koji
    Otsuka, Atsushi
    Funakoshi, Takeru
    Uchi, Hiroshi
    Fujimura, Taku
    Matsushita, Shigeto
    Hata, Hiroo
    Okuhira, Hisako
    Tanaka, Ryota
    Nagai, Kojiro
    Ishida, Yoshihiro
    Nakamura, Yoshio
    Furudate, Sadanori
    Yamamura, Kentaro
    Imafuku, Keisuke
    Yamamoto, Yuki
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2018, 89 (01) : 60 - 66
  • [10] The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis
    Furney, Simon J.
    Turajlic, Samra
    Stamp, Gordon
    Thomas, J. Meirion
    Hayes, Andrew
    Strauss, Dirk
    Gavrielides, Mike
    Xing, Wei
    Gore, Martin
    Larkin, James
    Marais, Richard
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2014, 27 (05) : 835 - 838